Price $4.00 |
Market Cap
376.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
8.59
|
P/S
0.95
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
52.0
|
Op. Cash Flow
13.6K
|
FCF
0.0
|
|
Op. Margin
-1.00%
|
Net Margin
-7.00%
|
ROE
-59.70%
|
ROI
-5.10%
|
|
ROA
-7.00%
|
EPS Growth
13.10%
|
Current Ratio
1.1
|
Debt/Equity
110.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Valeant Pharmaceuticals Intl I (VRX) | $24.27 | - | - | 7.68B | Strong Buy |
| Nature's Sunshine Prod. (NATR) | $9.25 | - | 4.40% | 172.5M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $23.99 | - | 3.90% | 22.05B | Strong Buy |
| NeoGenomics, Inc. (NEO) | $14.05 | - | - | 935.2M | Strong Buy |
| Neurometrix Inc (NURO) | $1.33 | - | - | 10M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
